For its second fiscal quarter (ending June 30), Nutrien Ltd (NYSE: NTR) has reported a -12% decline in E.P.S. from $0.89 a year ago to $0.78 in the current quarter. This result fell short of the consensus estimate of $2.19 by $-1.41. For the latest four quarters through June 30, E.P.S. were $1.60 versus $7.13 for the same period a year ago — a decline of -78%.
Recent Price Action
On 8/7/24, Nutrien Ltd (NYSE: NTR) stock declined slightly by -0.2%, closing at $47.08. Moreover, exceptionally high trading volume at 208% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -7.2% during the last week.
Current PriceTarget Research Rating
NTR’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a Value Builder.
Nutrien has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Nutrien has a very high Appreciation Score of 93 but a poor Power Rating of 17, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment